医学
过敏
过敏性
入射(几何)
特应性皮炎
低过敏性
安慰剂
益生元
累积发病率
免疫学
内科学
过敏原
胃肠病学
队列
生物
病理
物理
替代医学
光学
遗传学
作者
Sertaç Arslanoğlu,Guido E. Moro,Günther Boehm,F Wienz,Bernd Carsten Stahl,Enrico Bertino
出处
期刊:PubMed
日期:2013-04-08
卷期号:26 (3 Suppl): 49-59
被引量:115
摘要
Oligosaccharide prebiotics (scGOS/lcFOS), when started early in life have a protective effect against allergic manifestations in high risk infants. The protection lasts beyond infancy until 5 y of life, for AD and allergic rhinoconjunctivitis. Long-term follow-up studies in larger populations are warranted to evaluate the potential preventive effect of this mixture on asthma.
科研通智能强力驱动
Strongly Powered by AbleSci AI